| Host: |
Rabbit |
| Applications: |
IHC/IF/ELISA |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Slit homolog 3 protein (Internal) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IHC 1:100-1:300ELISA 1:40000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
SLIT3 |
| Gene ID: |
6586 |
| Uniprot ID: |
SLIT3_HUMAN |
| Immunogen Region: |
Internal |
| Specificity: |
Slit3 Polyclonal Antibody detects endogenous levels of Slit3 protein. |
| Immunogen: |
Synthesized peptide derived from the Internal region of human Slit3. |
| Function | May act as molecular guidance cue in cellular migration, and function may be mediated by interaction with roundabout homolog receptors. |
| Protein Name | Slit Homolog 3 ProteinSlit-3Multiple Epidermal Growth Factor-Like Domains Protein 5Multiple Egf-Like Domains Protein 5 |
| Database Links | Reactome: R-HSA-373752Reactome: R-HSA-376176Reactome: R-HSA-428542 |
| Cellular Localisation | Secreted |
| Alternative Antibody Names | Anti-Slit Homolog 3 Protein antibodyAnti-Slit-3 antibodyAnti-Multiple Epidermal Growth Factor-Like Domains Protein 5 antibodyAnti-Multiple Egf-Like Domains Protein 5 antibodyAnti-SLIT3 antibodyAnti-KIAA0814 antibodyAnti-MEGF5 antibodyAnti-SLIL2 antibodyAnti-UNQ691 antibodyAnti-PRO1336 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
